SAAS

FormBlends is a telehealth weight loss clinic that prescribes compounded semaglutide and tirzepatide to patients across the United States. These medications use the same active ingredients as Ozempic/Wegovy and Mounjaro/Zepbound, but are sourced from FDA-regulated 503B compounding pharmacies at a fraction of the brand-name cost. Here's why that matters. Brand-name Wegovy costs $1,300 to $1,600 per month without insurance. Brand-name Zepbound runs $1,000 to $1,200. FormBlends offers compounded semaglutide starting at $149/month and compounded tirzepatide starting at $299/month. No insurance required. No prior authorizations. No office visit. The process is straightforward. You complete a health questionnaire online, a licensed physician reviews your information and consults with you via telehealth, and if you qualify, your medication ships directly to your door within 3 to 5 business days. Everything is physician-supervised throughout the program, and your dosing gets adjusted as you progress. Semaglutide works by mimicking the GLP-1 hormone to slow digestion and reduce appetite. Dosing typically starts at 0.25mg weekly and increases gradually up to 2.4mg based on tolerance. Tirzepatide targets both GLP-1 and GIP receptors, making it a dual-agonist. In the SURMOUNT clinical trials, tirzepatide patients lost up to 22.5% of body weight over 68 weeks at the highest dose. The STEP trials showed 14.9% average weight loss with semaglutide over the same period. Individual results vary. Treatment requires a physician consultation.